Dashboard
Manage Tickers

KVUEKenvue Inc.

NYSE www.jnj.com/kenvue/


$ 20.55 $ -0.08 (-0.39 %)    

Wednesday, 15-May-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.83 $ 3.91 (0.87 %)
DIA $ 399.31 $ 3.73 (0.94 %)
SPY $ 529.09 $ 3.17 (0.6 %)
TLT $ 92.14 $ 1.28 (1.41 %)
GLD $ 220.89 $ 2.79 (1.28 %)
$ 20.54
$ 20.40
$ 0.00 x 0
$ 0.00 x 0
$ 20.13 - $ 20.73
$ 17.45 - $ 26.99
21,289,467
na
39.61B
$ 0.75
$ 26.57
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-01-2024 12-31-2023 10-K
3 11-03-2023 10-01-2023 10-Q
4 08-02-2023 07-02-2023 10-Q
5 06-02-2023 04-02-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Kenvue Priced Secondary Offering Of 182.3M...
05/14/2024 23:17:46

Core News & Articles
Kenvue Announces Launch of Secondary Offer...
05/13/2024 10:48:08

Kenvue Inc. (NYSE:KVUE) ("Kenvue") announced today the launch of a secondary underwritten public offering (the "Off...

Core News & Articles
Kenvue Filed For Offering Of 182.3M Shares...
05/13/2024 10:43:37

-S-1

in-depth-examination-of-7-analyst-recommendations-for-kenvue
In-Depth Examination Of 7 Analyst Recommen...
05/08/2024 18:01:14

hsbc-maintains-hold-on-kenvue-raises-price-target-to-21
HSBC Maintains Hold on Kenvue, Raises Pric...
05/08/2024 17:50:22

HSBC analyst Jeremy Fialko maintains Kenvue (NYSE:KVUE) with a Hold and raises the price target from $20 to $21.

us-stocks-eye-fourth-positive-session-despite-hawkish-fed-remarks-disney-palantir-tumble-treasury-yields-fall-whats-driving-markets-tuesday
US Stocks Eye Fourth Positive Session Desp...
05/07/2024 17:18:32

Wall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of significant economic data an...

band-aid-maker-kenvue-cuts-workforce-by-4-q1-earnings-beat-street-expectations
Band-Aid Maker Kenvue Cuts Workforce By 4%...
05/07/2024 16:52:30

Kenvue's first-quarter sales of $3.89 billion. Organic growth surged by 1.9% amidst strong demand in Self Care and Essentia...

kenvue-continues-to-expect-full-year-2024-adjusted-eps-of-110---120-versus-consensus-of-115
Kenvue Continues To Expect Full Year 2024 ...
05/07/2024 10:50:04

kenvue-expects-2024-reported-net-sales-growth-of-10-30-with-organic-growth-of-20-40
Kenvue Expects 2024 Reported Net Sales Gro...
05/07/2024 10:48:46

kenvue-q1-2024-adj-eps-028-beats-026-estimate-sales-3894b-beat-3790b-estimate
Kenvue Q1 2024 Adj EPS $0.28 Beats $0.26 E...
05/07/2024 10:46:58

looking-into-kenvues-recent-short-interest
Looking Into Kenvue's Recent Short Interest
04/24/2024 15:30:28

johnson--johnson-childrens-cough-syrup-contaminated-in-some-batches---who-poised-to-issue-global-alert-updated
Johnson & Johnson Children's Cough Syrup C...
04/23/2024 20:21:54

WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detect...

bernstein-initiates-coverage-on-kenvue-with-underperform-rating-announces-price-target-of-18
Bernstein Initiates Coverage On Kenvue wit...
04/11/2024 09:27:07

Bernstein analyst Callum Elliott initiates coverage on Kenvue (NYSE:KVUE) with a Underperform rating and announces Price Tar...

beyond-the-numbers-5-analysts-discuss-kenvue-stock
Beyond The Numbers: 5 Analysts Discuss Ken...
04/03/2024 17:00:43

william-blair-initiates-coverage-on-kenvue-with-market-perform-rating
William Blair Initiates Coverage On Kenvue...
04/03/2024 16:33:35

William Blair analyst Jon Andersen initiates coverage on Kenvue (NYSE:KVUE) with a Market Perform rating.

how-is-the-market-feeling-about-kenvue
How Is The Market Feeling About Kenvue?
03/29/2024 16:30:18

looking-into-kenvues-recent-short-interest
Looking Into Kenvue's Recent Short Interest
03/13/2024 19:00:20

watching-kenvue-shares-spike-higher-as-traders-circulate-analyst-comments-suggesting-tylenol-lawsuit-final-judgment-has-been-entered-in-favor-of-kvue-cases-are-dismissed
Watching Kenvue; Shares Spike Higher As Tr...
03/07/2024 15:36:49

goldman-sachs-maintains-neutral-on-kenvue-lowers-price-target-to-20
Goldman Sachs Maintains Neutral on Kenvue,...
03/04/2024 14:31:07

Goldman Sachs analyst Bonnie Herzog maintains Kenvue (NYSE:KVUE) with a Neutral and lowers the price target from $26 to $20.

goldman-sachs-downgrades-kenvue-to-neutral-maintains-price-target-to-20
Goldman Sachs Downgrades Kenvue to Neutral...
03/01/2024 12:00:15

Goldman Sachs analyst Bonnie Herzog downgrades Kenvue (NYSE:KVUE) from Buy to Neutral and maintains the price target from $2...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION